Literature DB >> 11909987

Depression associated with Parkinson's disease: clinical features and treatment.

Michael S Okun1, Ray L Watts.   

Abstract

Depression associated with Parkinson's disease (PD) is common and affects 25 to 40% of patients. Recognition of the signs and symptoms of depression associated with PD is essential for clinical practitioners. Treatment of depression in this subset of patients can have a direct and dramatic impact on functional disability and quality of life. A review of the literature concerning depression and depression associated with PD was undertaken, with specific attention given to disease mechanisms, clinical presentation, association with thyroid disease, and the principles of management and treatment. Specific signs and symptoms of depression can be easily identified in patients with PD. Practitioners should be aware of these signs and symptoms when diagnosing and treating depression associated with PD. Practitioners should also be aware of the pros and cons of each treatment option and should choose a therapy appropriate for each individual patient's needs. It is important to identify the features of depression associated with PD in order to render early diagnosis and institute practical and efficacious therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11909987     DOI: 10.1212/wnl.58.suppl_1.s63

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Gender and the Parkinson's disease phenotype.

Authors:  Yasuhiko Baba; John D Putzke; Nathaniel R Whaley; Zbigniew K Wszolek; Ryan J Uitti
Journal:  J Neurol       Date:  2005-09-12       Impact factor: 4.849

2.  Taste responses in patients with Parkinson's disease.

Authors:  H Sienkiewicz-Jarosz; A Scinska; W Kuran; D Ryglewicz; A Rogowski; E Wrobel; A Korkosz; A Kukwa; W Kostowski; P Bienkowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

Review 3.  Parkinson disease: an update.

Authors:  Steven J Frucht
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

4.  Emotional response in dopamine D2L receptor-deficient mice.

Authors:  Dubravka Hranilovic; Maja Bucan; Yanyan Wang
Journal:  Behav Brain Res       Date:  2008-09-18       Impact factor: 3.332

5.  Sertraline in the treatment of depressive disorders in patients with Parkinson's disease.

Authors:  Silvia Marino; Edoardo Sessa; Giuseppe Di Lorenzo; Giuseppina Digangi; Antonella Alagna; Placido Bramanti; Paolo Di Bella
Journal:  Neurol Sci       Date:  2008-11-11       Impact factor: 3.307

Review 6.  Emotional dysfunction in Parkinson's disease.

Authors:  Lee X Blonder; John T Slevin
Journal:  Behav Neurol       Date:  2011       Impact factor: 3.342

7.  Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan.

Authors:  Teruhiko Higuchi; Mike Briley
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

Review 8.  Neuropsychiatric Disorders in Parkinson's Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?

Authors:  Kathy Dujardin; Véronique Sgambato
Journal:  Front Neurosci       Date:  2020-01-29       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.